Revenue
2021
2022
Pasithea Therapeutics Corp. (KTTA)
Price—Loading quote
Net income
2021
2022
2023
2024
2025
Free cash flow
2021
2022
2023
Total cash / debt
CashTotal debt
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | — | — | — | $486,559 | $15,062 |
| Gross profit | — | — | — | — | −$2,213 |
| Research & development | $8.0M | $7.2M | $8.1M | $2.7M | — |
| Operating income | −$20.9M | −$14.2M | −$16.0M | −$12.6M | −$4.5M |
| Net income | −$20.4M | −$13.9M | −$16.0M | −$13.9M | −$2.2M |
| Basic EPSper diluted share | -$2.91 | -$12.69 | -$0.42 | -$1.76 | -$0.21 |
| Diluted EPSper diluted share | -$2.91 | -$12.69 | -$0.42 | -$1.76 | -$0.21 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 17, 2026Form 4 | Coastlands Capital LPTenPercentOwner | BuyCommon Stock · indirect | 100.0K | $0.53 | $53.0K | 3.84M |
| Nov 28, 2025Form 4 | STEINMAN LAWRENCEDirector | BuyCommon Stock | 133.3K | $0.75 | $100.0K | 199.7K |
| Nov 28, 2025Form 4 | Marques TiagoChief Executive Officer | BuyCommon Stock | 33.3K | $0.75 | $25.0K | 73.3K |
| Nov 28, 2025Form 4 | Dumesnil SimonDirector | BuyCommon Stock | 33.3K | $0.75 | $25.0K | 35.8K |
| May 12, 2025Form 4 | Marques TiagoChief Executive Officer | SellCommon Stock | 960 | $0.83 | $796.80 | 40.0K |